LexDanaLexDanabeta
Inventor

Tao Wang

Inventor
Farmington, CT, US

Overview

134→
Patents
2002–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 134 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12NMicroorganisms or enzymes3%
C07KPeptides2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,815,287Acylated derivative of human insulin or analogue thereof202010,787,446Therapeutic compounds and methods of use thereof202010,577,3535-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication202010,570,108Substituted benzofuran compounds for the treatment of hepatitis C202010,556,964Bispecific antibody-mediated cancer therapy with cytokine-induced killer cell202010,520,472System and method of measuring cell viability and growth201910,407,410Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication201910,391,113Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient201910,392,352Etomidate derivative and intermediate, preparation method and use thereof201910,323,237Lysozyme having improved enzymatic activity201910,280,183Therapeutic agent for treating tumors201910,258,572Pharmaceutical compositions of goserelin sustained release microspheres201910,239,851Carboxylic acid derivatives and use thereof in the preparation of prodrugs201910,214,5165-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication201910,214,534Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C201910,202,403Macrocyclic benzofuran compounds for the treatment of hepatitis C201910,189,816Substituted pyridines as inhibitors of human immunodeficiency virus replication201910,144,706Compounds useful as immunomodulators201810,138,256MK2 inhibitors and uses thereof201810,131,645Benzofurans substituted with primary benzamide as HCV inhibitors201810,125,111Benzofuran compounds for the treatment of hepatitis C201810,125,137Benzofurans substituted with bicyclic secondary benzamide as HCV inhibitors201810,087,167Benzofurans substituted with secondary benzamide as HCV inhibitors201810,029,014Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery20189,994,578Benzodiazepine derivative and use thereof20189,969,732Tetrahydroisoquinoline estrogen receptor modulators and uses thereof20189,957,278Furopyridine compounds for the treatment of hepatitis C20189,920,036'Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis C'20189,918,988'Ammonium derivatives for the treatment of hepatitis C'20189,914,739'6H-furo[2,3-E]indole compounds for the treatment of hepatitis C'20189,873,707Methods and intermediates for preparing macrolactams20189,868,743'Macrocyclic molecules as HCV entry inhibitors'20189,840,511'2-(aryl or heteroaryl-)phenyl (AZA)benzofuran compounds for the treatment of hepatitis C'20179,834,566Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication20179,777,073'Construction and application of bispecific antibody EpCAM×CD3'20179,758,818'Polymerase chain reaction-based method and primer set for detecting epidermal growth factor receptor mutation'20179,745,322'Compounds for the treatment of hepatitis C'20179,655,888'Tricyclic alkene derivatives as HIV attachment inhibitors'20179,656,992'Pyrimidine compounds for the treatment of hepatitis C'20179,655,902'Guanidine derivatives for the treatment of hepatitis C'20179,650,390'Water-soluble taxane derivatives and uses thereof'20179,643,917'Water-soluble propofol derivatives and uses thereof'20179,624,180'Squaric derivatives for the treatment of hepatitis C'20179,624,245'Macrocyclic compounds as HCV entry inhibitors'20179,586,957'2-keto amide derivatives as HIV attachment inhibitors'20179,505,752'Piperidine amide derivatives as HIV attachment inhibitors'20169,434,738'Macrocyclic benzofuran and azabenzofuran compounds for the treatment of hepatitis C'20169,428,802'Selective-competitive primer and method of use'20169,422,311'Compounds for the treatment of hepatitis C'20169,249,152'Cyano containing azabenzofuran compounds for the treatment of hepatitis C'20169,238,604'Process and intermediates for preparing macrolactams'20169,193,725'Cyclic hydrazine derivatives as HIV attachment inhibitors'20159,193,720'Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication'20159,163,218'Method for increasing the efficiency of inducing pluripotent stem cells'20159,163,217'Method for increasing the efficiency of inducing pluripotent stem cells'20159,156,828'Tricyclic amidine derivatives as HIV attachment inhibitors'20158,987,265'Substituted 1,3,5-triazine derivatives of fused bicyclic oxalamide compounds for treatment of Hepatitis C'20158,987,264'1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C'20158,933,066'Compounds for the treatment of hepatitis C'20158,916,702'Compounds for the treatment of hepatitis C'20148,912,195'Alkyl amides as HIV attachment inhibitors'20148,871,771'Salts of prodrugs of piperazine and substituted piperidine antiviral agents'20148,835,454'Fused bicyclic diamine derivatives as HIV attachment inhibitors'20148,835,465'Pyrazolylaminopyridine derivatives useful as kinase inhibitors'20148,815,600'Homologous recombination-based DNA cloning methods and compositions'20148,765,944'Compounds for the treatment of hepatitis C'20148,741,884'Compounds for the treatment of hepatitis C'20148,685,982'Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors'20148,664,213'Spiro bicyclic diamine derivatives as HIV attachment inhibitors'20148,629,150'Compounds for the treatment of hepatitis C'20148,618,314'Exo- and diastereo-selective synthesis of himbacine analogs'20138,586,584'Compounds for the treatment of hepatitis C'20138,557,302'Andrographis paniculata extract'20138,557,308'Andrographis paniculata extract'20138,501,454'Homologous recombination-based DNA cloning compositions'20138,486,966'9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer'20138,461,333'Salts of prodrugs of piperazine and substituted piperidine antiviral agents'20138,450,361'Substituted indole and azaindole oxoacetyl piperazinamide derivatives'20138,445,532'Use of phthalide derivatives'20138,445,490'Compounds for the treatment of hepatitis C'20138,324,252'Pyrazolylaminopyridine derivatives useful as kinase inhibitors'20128,273,790'Exo-selective synthesis of himbacine analogs'20128,258,319'Exo- and diastereo- selective synthesis of himbacine analogs'20128,247,444'Anti-tumor effect of dimeric phthalide compound'20128,242,124'Diketopiperidine derivatives as HIV attachment inhibitors'2012RE043423'Crude extracts from Andrographis paniculata '20128,168,615'Prodrugs of piperazine and substituted piperidine antiviral agents'20128,138,180'Exo-selective synthesis of himbacine analogs'20128,129,403'Chemical compounds'20128,124,615'Diketo substituted pyrrolo[2,3-C]pyridines'20128,114,989'Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors'20128,088,784'4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer'2012RE042718'Crude extracts from andrographis paniculata'20117,989,653'Exo- and diastereo-selective syntheses of himbacine analogs'20117,960,406'Diketo substituted pyrrolo[2,3-c] pyridines'20117,915,283'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20117,902,359'Decahydronaphthalene compounds'20117,807,676'Diketo-Piperazine and Piperidine derivatives as antiviral agents'20107,807,671'Diketo-piperazine and piperidine derivatives as antiviral agents'20107,772,276'Exo-selective synthesis of himbacine analogs'20107,745,463'Alkene piperidine derivatives as antiviral agents'20107,745,625'Prodrugs of piperazine and substituted piperidine antiviral agents'20107,714,019'Indole, azaindole and related heterocyclic pyrrolidine derivatives'20107,678,948'Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof'20107,662,823'Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives'20107,626,045'Synthesis of himbacine analogs'20097,625,945'Andrographolide and analogues as inhibitors of TNFα and IL-1β expression'20097,622,465'Costunolide derivatives'20097,622,482'Chemical compounds'20097,605,275'Exo- and diastereo- selective syntheses of himbacine analogs'20097,572,810'Alkene piperidine derivatives as antiviral agents'20097,553,987'Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof'20097,541,471'Synthesis of himbacine analogs'20097,531,552'Indole, azaindole and related heterocyclic pyrrolidine derivatives'20097,504,399'Piperazine enamines as antiviral agents'20097,501,420'Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives'20097,488,836'Costunolide derivatives'20097,396,830'Piperazine amidines as antiviral agents'20087,354,924'Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives'20087,348,337'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20087,341,748'Crude extracts from Andrographis paniculata '20087,304,092'Compounds and methods for treating tumors, cancer and hyperproliferative diseases'20077,098,005'Natural promoters for gene expression in C1 metabolizing bacteria'20067,087,610'Benzothiazole antiviral agents'20067,037,913'Bicyclo 4.4.0 antiviral derivatives'20067,026,464'Natural promoters for gene expression in C1 metabolizing bacteria'20066,900,323'Antiviral azaindole derivatives'20056,825,201'Indole, azaindole and related heterocyclic amidopiperazine derivatives'20046,632,819'Antiviral azaindole derivatives'20036,617,148'Natural promoters for gene expression and metabolic monitoring in bacillus species'20036,573,262'Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives'20036,537,786'Genes encoding exopolysaccharide production'20036,476,034'Antiviral azaindole derivatives'20026,469,006'Antiviral indoleoxoacetyl piperazine derivatives'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2020Patents assigned to BRISTOL MYERS SQUIBB CO (66)· patent assignee history
2002–2010Based in Middletown, CT, US· patent location history
2008–2020Based in Farmington, CT, US· patent location history
2008–2020Based in Shanghai, CN· patent location history
2009–2012Patents assigned to SCHERING CORP (10)· patent assignee history
2009–2013Based in Springfield, NJ, US· patent location history
2012–2019Patents assigned to WANG TAO (33)· patent assignee history
2012–2014Patents assigned to ZHANG ZHONGXING (13)· patent assignee history
2012–2014Patents assigned to KADOW JOHN F (8)· patent assignee history
2017–2020Based in Wallingford, CT, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO662002–2020
WANG TAOself332012–2019
ZHANG ZHONGXING132012–2014
SCHERING CORP102009–2012
KADOW JOHN F82012–2014
Locations
LocationPatentsSpan
Farmington, CT, US592008–2020
Shanghai, CN112008–2020
Middletown, CT, US112002–2010
Springfield, New Jersey, US102009–2013
Wallingford, CT, US52017–2020